Aside from molecules that can mediate these events directly and, in a dose-response manner (e.g., IL-6), adult neurogenesis sites such as the hippocampi and the olfactory network would be particularly vulnerable, accounting for the selective vulnerability of these networks and the resulting anosmia-cognitive impairment phenotype we report on. The gene discussed is IL6; the disease is Kallmann syndrome.